CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to ABBV

Ravagalimab

Phase 2
AbbVie Inc. (ABBV)

Phase 2

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Feb '27
ABBVPhase 2

Ravagalimab Phase 2 Est. Readout

Ravagalimab
Feb 2027~STALE
CT.gov
00%
Drug Information

Target Indication

Rheumatoid Arthritis

Clinical Trial

NCT06972446

Last updated: 1/2/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.